TY - JOUR
T1 - Particle size analysis in pharmaceutics
T2 - Principles, methods and applications
AU - Shekunov, Boris Y.
AU - Chattopadhyay, Pratibhash
AU - Tong, Henry H.Y.
AU - Chow, Albert H.L.
N1 - Funding Information:
One of the authors (Henry H. Y. Tong) would like to acknowledge the financial support of Macao Polytechnic Institute [Project No. RP/ESS-7/2005].
PY - 2007/2
Y1 - 2007/2
N2 - Physicochemical and biopharmaceutical properties of drug substances and dosage forms can be highly affected by the particle size, a critical process parameter in pharmaceutical production. The fundamental issue with particle size analysis is the variety of equivalent particle diameters generated by different methods, which is largely ascribable to the particle shape and particle dispersion mechanism involved. Thus, to enable selection of the most appropriate or optimal sizing technique, cross-correlation between different techniques may be required. This review offers an in-depth discussion on particle size analysis pertaining to specific pharmaceutical applications and regulatory aspects, fundamental principles and terminology, instrumentation types, data presentation and interpretation, in-line and process analytical technology. For illustration purposes, special consideration is given to the analysis of aerosols using time-of-flight and cascade impactor measurements, which is supported by a computational analysis conducted for this review.
AB - Physicochemical and biopharmaceutical properties of drug substances and dosage forms can be highly affected by the particle size, a critical process parameter in pharmaceutical production. The fundamental issue with particle size analysis is the variety of equivalent particle diameters generated by different methods, which is largely ascribable to the particle shape and particle dispersion mechanism involved. Thus, to enable selection of the most appropriate or optimal sizing technique, cross-correlation between different techniques may be required. This review offers an in-depth discussion on particle size analysis pertaining to specific pharmaceutical applications and regulatory aspects, fundamental principles and terminology, instrumentation types, data presentation and interpretation, in-line and process analytical technology. For illustration purposes, special consideration is given to the analysis of aerosols using time-of-flight and cascade impactor measurements, which is supported by a computational analysis conducted for this review.
KW - Aerodynamic diameter
KW - Aerosols
KW - Agglomeration
KW - Dispersion
KW - Impactor
KW - Inhaler
KW - Micro and nanosuspensions
KW - PAT
KW - Particle size distribution
KW - Powders
KW - Respiratory drug delivery
KW - Shape
KW - Tablets
UR - http://www.scopus.com/inward/record.url?scp=33846061644&partnerID=8YFLogxK
U2 - 10.1007/s11095-006-9146-7
DO - 10.1007/s11095-006-9146-7
M3 - Review article
C2 - 17191094
AN - SCOPUS:33846061644
SN - 0724-8741
VL - 24
SP - 203
EP - 227
JO - Pharmaceutical Research
JF - Pharmaceutical Research
IS - 2
ER -